Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns

被引:1602
作者
Bachmann, Martin F. [1 ]
Jennings, Gary T. [1 ]
机构
[1] Biotechnol AG, CH-8952 Zurich, Switzerland
关键词
T-CELL RESPONSES; PLASMACYTOID DENDRITIC CELLS; HUMORAL IMMUNE-RESPONSE; MHC CLASS-I; B-CELLS; LYMPH-NODES; PERSISTING ANTIGEN; SUBCAPSULAR SINUS; CUTTING EDGE; ADJUVANT;
D O I
10.1038/nri2868
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Researchers working on the development of vaccines face an inherent dilemma: to maximize immunogenicity without compromising safety and tolerability. Early vaccines often induced long-lived protective immune responses, but tolerability was a major problem. Newer vaccines have very few side effects but can be of limited immunogenicity. One way to tackle this problem is to design vaccines that have all the properties of pathogens with the exception of causing disease. Key features of pathogens that can be mimicked by vaccine delivery systems are their size, shape and surface molecule organization. In addition, pathogen-associated molecular patterns can be used to induce innate immune responses that promote adaptive immunity. In this Review, we discuss the approaches currently being used to optimize the delivery of antigens and enhance vaccine efficacy.
引用
收藏
页码:787 / 796
页数:10
相关论文
共 120 条
[41]   DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells [J].
Geijtenbeek, TBH ;
Kwon, DS ;
Torensma, R ;
van Vliet, SJ ;
van Duijnhoven, GCF ;
Middel, J ;
Cornelissen, ILMHA ;
Nottet, HSLM ;
KewalRamani, VN ;
Littman, DR ;
Figdor, CG ;
van Kooyk, Y .
CELL, 2000, 100 (05) :587-597
[42]   Capture of influenza by medullary dendritic cells via SIGN-R1 is essential for humoral immunity in draining lymph nodes [J].
Gonzalez, Santiago F. ;
Lukacs-Kornek, Veronika ;
Kuligowski, Michael P. ;
Pitcher, Lisa A. ;
Degn, Soren E. ;
Kim, Young-A ;
Cloninger, Mary J. ;
Martinez-Pomares, Luisa ;
Gordon, Siamon ;
Turley, Shannon J. ;
Carroll, Michael C. .
NATURE IMMUNOLOGY, 2010, 11 (05) :427-U90
[43]   Effect of the strength of adsorption of hepatitis B surface antigen to aluminum hydroxide adjuvant on the immune response [J].
Hansen, Bethany ;
Belfast, Mary ;
Soung, George ;
Song, Liping ;
Egan, Patricia M. ;
Capen, Robert ;
HogenEsch, Harm ;
Mancinelli, Ralph ;
Hem, Stanley L. .
VACCINE, 2009, 27 (06) :888-892
[44]   Relationship between the strength of antigen adsorption to an aluminum-containing adjuvant and the immune response [J].
Hansen, Bethany ;
Sokolovska, Anna ;
HogenEsch, Harm ;
Hem, Stanley L. .
VACCINE, 2007, 25 (36) :6618-6624
[45]  
HARDING CV, 1994, J IMMUNOL, V153, P4925
[46]   Toll or toll-free adjuvant path toward the optimal vaccine development [J].
Ishii, Ken J. ;
Akira, Shizuo .
JOURNAL OF CLINICAL IMMUNOLOGY, 2007, 27 (04) :363-371
[47]  
JANEWAY CA, 1989, COLD SH Q B, V54, P1
[48]  
Jegerlehner A, 2002, EUR J IMMUNOL, V32, P3305, DOI 10.1002/1521-4141(200211)32:11<3305::AID-IMMU3305>3.0.CO
[49]  
2-J
[50]   TLR9 signaling in B cells determines class switch recombination to IgG2a [J].
Jegerlehner, Andrea ;
Maurer, Patrik ;
Bessa, Juliana ;
Hinton, Heather J. ;
Kopf, Manfred ;
Bachmann, Martin F. .
JOURNAL OF IMMUNOLOGY, 2007, 178 (04) :2415-2420